FindMyKOL
Clinical trialNCT03148691CompletedPhase 2Interventional

A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis

SponsorAclaris Therapeutics, Inc.Enrollment253Seborrheic Keratosis
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The primary objective of this study is to evaluate the safety and effectiveness of 2 concentrations of A-101 compared to Vehicle for the treatment of 4 seborrheic keratosis (SK) Target Lesions on the trunk, extremities and face.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Center for Dermatology and Dermatologic Surgery

    Washington D.C., District of Columbia, United States

  • Baumann Research Institute

    Miami, Florida, United States

  • Medaphase, Inc

    Newnan, Georgia, United States

  • Union Square Laser Dermatology

    New York, New York, United States

  • Philadelphia Institute - Dermatology

    Fort Washington, Pennsylvania, United States

  • Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania, United States

  • Greenville Dermatology

    Greenville, South Carolina, United States

  • the Skin Wellness Center, Pc Clinical Research Division

    Knoxville, Tennessee, United States

  • Dermresearch Inc

    Austin, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

A-101
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 May 2017
Primary completion
28 Feb 2018
Completion
3 Apr 2018
Last update posted
6 May 2019
Registered enrollment
253
Registry id
NCT03148691
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.